ATN 064 Other Hematology Results Dataset in Immunogenicity, Safety, Tolerability, and Behavioral Consequences of an HPV-6, -11, -16, -18 Vaccine in HIV-Infected Young Women

Dataset with no observations
Study Description
A Phase II, open-label, multi-center study that evaluated the immunogenicity, safety, tolerability, and behavioral impact of an HPV-6, -11, -16, -18 vaccine in HIV-infected young women. The vaccine was administered at the recommended dose and schedule (Day 0, Week 8, and Week 24) with safety assessments after each vaccination and reactive antibody measurements pre- and post-vaccination. Attitudes and behaviors were measured using self-administered questionnaires.
HIV-infected young women between 16 and 23 years of age

不含观测样本的数据集
研究概况
本研究为一项二期、开放标签、多中心临床试验，旨在评估6、11、16、18型人乳头瘤病毒（Human Papillomavirus，HPV）疫苗在人类免疫缺陷病毒（Human Immunodeficiency Virus，HIV）感染青年女性中的免疫原性、安全性、耐受性及行为学影响。该疫苗按照推荐剂量与免疫程序（第0天、第8周及第24周）实施接种，每次接种后均开展安全性评估，并于疫苗接种前后检测反应性抗体水平。研究对象的态度与行为通过自填式问卷进行测评。
研究对象为16至23岁的HIV感染青年女性。